c-Myc activation in early coronary lesions in experimental hypercholesterolemia

Biochemical and Biophysical Research Communications

Volumn 281, Issue 4, 2001, Pages 945-950

  De Nigris, F ^a,b   Lerman, L O ^c   Rodriguez Porcel, M ^c   De Montis, M P ^d   Lerman, A ^c   Napoli, C ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF SASSARI   (Italy)

Author keywords

Antioxidants; Atherogenesis; C Myc

Indexed keywords

ANTIOXIDANT; BINDING PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MAX PROTEIN; MYC PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VITAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; DIET; HYPERCHOLESTEROLEMIA; NONHUMAN; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

EID: 0034811562     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4431     Document Type: Article

References (32)

1. Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors
2. Multiple signals converging on NF-kappaB
3. c-Myc target genes involved in cell growth, apoptosis, and metabolism
4. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation
5. Evidence for oxidative activation of c-myc-dependent nuclear signaling in human coronary smooth muscle cells and in early lesions of Watanabe heritable hyperlipidemic rabbits: Protective effects of vitamin E
6. Vitamin E and heart disease: Basic science to clinical intervention trials
7. Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene
8. Distribution of c-myc oncoprotein in healthy and atherosclerotic human carotid arteries
9. c-MYC oncoprotein production in experimental vein graft intimal hyperplasia
10. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries
11. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery
12. Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandin F2a, in experimental hypercholesterolemia
13. Experimental hypercholesterolemia induces ultrastructural changes in the internal elastic lamina of porcine coronary arteries
14. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia
15. Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia
16. Coronary artery apoptosis in experimental hypercholesterolemia
17. Hypercholesterolemia impairs myocardial perfusion and permeability: Role of oxidative stress and endogenous scavenging activity
18. A simple and rapid purification procedure minimizes spontaneous oxidative modifications of low density lipoprotein and lipoprotein (a)
19. Protein measurement with the folin phenol reagent
20. Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals
21. Low-dose angiotensin II increases free isoprostane levels in plasma
22. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia
23. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions
24. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of early lesions in children (FELIC) study
25. Modulation by alpha- and gamma-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells
26. Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart
27. Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia
28. Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia
29. Sustained reduction of neointima with c-myc antisense oligonucleotides in saphenous vein grafts
30. cdc25A is necessary but not sufficient for optimal c-myc-induced apoptosis and cell proliferation of vascular smooth muscle cells
31. Atherosclerosis - An inflammatory disease
32. Vitamin E and vascular homeostasis: Implications for atherosclerosis